Format

Send to

Choose Destination
Eur J Cancer. 2019 Apr 12;113:75-77. doi: 10.1016/j.ejca.2019.03.011. [Epub ahead of print]

Melanoma during fingolimod treatment for multiple sclerosis.

Author information

1
Dermatology Unit, Oncology Department, Gustave Roussy, 94805 Villejuif, France. Electronic address: Charles.velter@gmail.com.
2
Dermatology Unit, Oncology Department, Gustave Roussy, 94805 Villejuif, France.
3
Surgery Department, Gustave Roussy, 94805 Villejuif, France.
4
Dermatologue de ville, 1 square de La Mutualité, 75005 Paris, France.
5
Neurology Department, Pitié-Salpêtrière Hospital, APHP and Sorbonne University, 75013 Paris, France.
6
Dermatology Unit, Oncology Department, Gustave Roussy, 94805 Villejuif, France; Paris-Sud University, Kremlin-Bicêtre, France.

KEYWORDS:

Adverse effect; FTY720; Fingolimod; Melanoma; Multiple sclerosis; Side effect

PMID:
30986706
DOI:
10.1016/j.ejca.2019.03.011

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center